RU2009117219A - METHOD FOR DETERMINING THE DEGREE OF PHYSICAL ACTIVITY OF PATIENTS - Google Patents

METHOD FOR DETERMINING THE DEGREE OF PHYSICAL ACTIVITY OF PATIENTS Download PDF

Info

Publication number
RU2009117219A
RU2009117219A RU2009117219/14A RU2009117219A RU2009117219A RU 2009117219 A RU2009117219 A RU 2009117219A RU 2009117219/14 A RU2009117219/14 A RU 2009117219/14A RU 2009117219 A RU2009117219 A RU 2009117219A RU 2009117219 A RU2009117219 A RU 2009117219A
Authority
RU
Russia
Prior art keywords
physical activity
day
steps
restrictions
patients
Prior art date
Application number
RU2009117219/14A
Other languages
Russian (ru)
Other versions
RU2423915C2 (en
Inventor
Виктор Петрович Дору-Товт (RU)
Виктор Петрович Дору-Товт
Original Assignee
Государственное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе (RU)
Государственное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе (RU), Государственное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе filed Critical Государственное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе (RU)
Priority to RU2009117219/14A priority Critical patent/RU2423915C2/en
Publication of RU2009117219A publication Critical patent/RU2009117219A/en
Application granted granted Critical
Publication of RU2423915C2 publication Critical patent/RU2423915C2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Способ определения степени физической активности пациентов, основанный на количественной оценке ходьбы, отличающийся тем, что проводят мониторирование ходьбы пациентов в течение всего междиализного периода с помощью динамического шагомера и при показании шагомера менее 1500 шагов/сутки определяют абсолютные ограничения физической активности; от 1500 до 3000 шагов/сутки - тяжелые ограничения физической активности; от 3000 до 6000 шагов/сутки - умеренные ограничения физической активности; от 6000 до 10000 шагов/сутки - легкие ограничения физической активности; более 10000 шагов/сутки - отсутствие ограничений физической активности. A method for determining the degree of physical activity of patients based on a quantitative assessment of walking, characterized in that they monitor the walking of patients throughout the interdialysis period using a dynamic pedometer, and when the pedometer shows less than 1500 steps / day, absolute restrictions on physical activity are determined; from 1500 to 3000 steps / day - severe restrictions on physical activity; from 3000 to 6000 steps / day - moderate restrictions on physical activity; from 6000 to 10000 steps / day - slight restrictions on physical activity; more than 10,000 steps / day - no restrictions on physical activity.

Claims (1)

Способ определения степени физической активности пациентов, основанный на количественной оценке ходьбы, отличающийся тем, что проводят мониторирование ходьбы пациентов в течение всего междиализного периода с помощью динамического шагомера и при показании шагомера менее 1500 шагов/сутки определяют абсолютные ограничения физической активности; от 1500 до 3000 шагов/сутки - тяжелые ограничения физической активности; от 3000 до 6000 шагов/сутки - умеренные ограничения физической активности; от 6000 до 10000 шагов/сутки - легкие ограничения физической активности; более 10000 шагов/сутки - отсутствие ограничений физической активности. A method for determining the degree of physical activity of patients based on a quantitative assessment of walking, characterized in that they monitor the walking of patients throughout the interdialysis period using a dynamic pedometer, and when the pedometer shows less than 1500 steps / day, absolute restrictions on physical activity are determined; from 1500 to 3000 steps / day - severe restrictions on physical activity; from 3000 to 6000 steps / day - moderate restrictions on physical activity; from 6000 to 10000 steps / day - slight restrictions on physical activity; more than 10,000 steps / day - no restrictions on physical activity.
RU2009117219/14A 2009-05-05 2009-05-05 Method of determining degree of patients' physical activity RU2423915C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2009117219/14A RU2423915C2 (en) 2009-05-05 2009-05-05 Method of determining degree of patients' physical activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2009117219/14A RU2423915C2 (en) 2009-05-05 2009-05-05 Method of determining degree of patients' physical activity

Publications (2)

Publication Number Publication Date
RU2009117219A true RU2009117219A (en) 2010-11-10
RU2423915C2 RU2423915C2 (en) 2011-07-20

Family

ID=44025846

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009117219/14A RU2423915C2 (en) 2009-05-05 2009-05-05 Method of determining degree of patients' physical activity

Country Status (1)

Country Link
RU (1) RU2423915C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2712011C2 (en) * 2018-06-14 2020-01-23 Радмир Амирович Саубанов Functional activity evaluation method

Also Published As

Publication number Publication date
RU2423915C2 (en) 2011-07-20

Similar Documents

Publication Publication Date Title
EA201491605A1 (en) WAYS TO IMPROVE THE DIAPHRAGM FUNCTION
FR2883179B1 (en) COATED TABLET
BRPI0909179A2 (en) Pharmaceutical composition and method of treatment of an autoimmune disease.
CL2017002781A1 (en) Alzheimer's disease treatment methods
EA201300084A1 (en) METHOD OF STERILIZATION AT THE LESSER MEASURE OF A SINGLE OBJECT, STERILIZATION DEVICE AND ITS APPLICATION
MA32349B1 (en) ANTAGONISTS OF THE HEDGEHOG PATHWAY BASED ON DISUBSTITUTED PHTALAZINES
EA201001402A1 (en) PHARMACEUTICAL SOLUTIONS, METHOD FOR OBTAINING AND THERAPEUTIC APPLICATION
EP2596122A4 (en) Modulators for sirt5 and assays for screening same
WO2011153428A8 (en) System and method for assessing a likelihood of a patient to experience a future cardiac arrhythmia using dynamic changes in a biological parameter
EA201290808A1 (en) SUBSTITUTED CONDENSED DERIVATIVES OF IMIDAZOL, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR USE
EA201071209A1 (en) APPLICATION OF DRUNEDARON OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR OBTAINING A MEDICINE TO REGULATE KALIUM IN THE BLOOD
EA201190313A1 (en) SUBSTITUTED PIPERIDINES
EA200970816A1 (en) NEW MEDICINE FORM
DK2276569T3 (en) Blood collection kit, preferably peripheral blood, for the production of stem cells
RU2009117219A (en) METHOD FOR DETERMINING THE DEGREE OF PHYSICAL ACTIVITY OF PATIENTS
ITFI20080024A1 (en) METHOD OF INCREASING CORRECTION OF THE DORSAL HYPER-GLOSSIS AND ORTHOPEDIC TUTOR FOR ITS IMPLEMENTATION.
IT1401767B1 (en) FOOTWEAR FOR THE CORRECTION OF ANATOMICAL DEFECTS OR OF WALKING.
EA201070945A1 (en) NONIMMUNOSUPRESSOR CYCLOSPORIN FOR THE TREATMENT OF MUSCULAR DYSTROPHY
ITTO20080021A1 (en) FOOTWEAR, IN PARTICULAR FOR THE PREVENTION AND CORRECTION OF THE VALGO ALLUCE
WO2011106378A3 (en) Oral b12 therapy
FR2916141B1 (en) RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO.
IT1402413B1 (en) MEASUREMENT SYSTEM FOR SOIL HUMIDITY.
UA53584U (en) Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
UA53578U (en) Method for assessing treatment efficacy of trandolopril in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
UA100553C2 (en) Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110513